Search | WHO COVID-19 Research Database

Emergence of the SARS-CoV-2 B.1.1.7 variant observed at the Poitiers University Hospital.

Hubert, Florent; Chessa, Céline; Beby-Defaux, Agnès; Bourgoin, Anne; Boinot, Laurence; Noury, Ursula; Lariviere, Andy; Benlaassri, Mohammed; Garcia, Magali; Leveque, Nicolas.

J Med Virol ; 93(9): 5254-5256, 2021 Sep.

Article in English | MEDLINE | ID: covidwho-1231860

Subject(s)

COVID-19 , Hospitals, University , SARS-CoV-2/isolation & purification , COVID-19/diagnosis , COVID-19/epidemiology , France/epidemiology , Humans

Regarding Use of Povidone Iodine to Reduce Nasopharyngeal Viral Load in Patients With COVID-19-Reply.

Guenezan, Jérémy; Garcia, Magali; Mimoz, Olivier.

JAMA Otolaryngol Head Neck Surg ; 147(7): 681, 2021 07 01.

Article in English | MEDLINE | ID: covidwho-1206736

Subject(s)

COVID-19 , Povidone-Iodine , Humans , Nasopharynx , SARS-CoV-2 , Viral Load

Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial.

Guenezan, Jeremy; Garcia, Magali; Strasters, Deidre; Jousselin, Clément; Lévêque, Nicolas; Frasca, Denis; Mimoz, Olivier.

JAMA Otolaryngol Head Neck Surg ; 147(4): 400-401, 2021 04 01.

Article in English | MEDLINE | ID: covidwho-1064297

Subject(s)

Anti-Infective Agents, Local/administration & dosage , COVID-19/virology , Mouthwashes , Nasal Sprays , Nasopharynx/virology , Povidone-Iodine/administration & dosage , Viral Load , Aged , Anti-Infective Agents, Local/adverse effects , Female , Humans , Male , Middle Aged , Povidone-Iodine/adverse effects , SARS-CoV-2 , Thyrotropin/blood , Thyrotropin/drug effects

Subject(s)

Subject(s)

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL